arginine has been researched along with Diabetic Angiopathies in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.94) | 18.7374 |
| 1990's | 14 (20.59) | 18.2507 |
| 2000's | 23 (33.82) | 29.6817 |
| 2010's | 28 (41.18) | 24.3611 |
| 2020's | 1 (1.47) | 2.80 |
| Authors | Studies |
|---|---|
| Adamiec, R; Dumas, I; Fiodorenko-Dumas, Z; Małecki, R; Paprocka-Borowicz, M; Rabczynski, M | 1 |
| Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P | 1 |
| Ajjan, R; Anderssohn, M; Böger, RH; Grant, PJ; Lüneburg, N; McLachlan, S; Price, JF; Robertson, C; Schwedhelm, E; Strachan, MW; Williamson, RM | 1 |
| Barzilay, JI; Fonseca, V; Goldfine, AB; Jablonski, KA; Monnier, VM; Shoelson, SE; Strauch, C | 1 |
| Akalin, A; Arabul, M; Celik, M; Cerrah, S | 1 |
| Bob, F; Dumitrascu, V; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Jianu, DC; Petrica, L; Petrica, M; Popescu, R; Ursoniu, S; Velciov, S; Vlad, A; Vlad, D | 1 |
| Chyrchel, B; Golay, A; Kruszelnicka, O; Surdacki, A | 1 |
| Kaneko, K; Kuroyanagi, Y; Takaya, J; Tanabe, Y | 1 |
| Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
| He, J; Jing, Z; Kuang, L; Liu, N; Sun, Z; Wang, Y; Yang, J | 1 |
| Chrysis, D; Efthymiadou, A; Kritikou, D; Mermigka, A; Spiliotis, BE | 1 |
| Kövamees, O; Pernow, J; Shemyakin, A | 1 |
| Checa, A; Kövamees, O; Lundberg, JO; Östenson, CG; Pernow, J; Shemyakin, A; Wheelock, CE | 1 |
| Dagnelie, PC; Henry, RM; Koster, A; Kroon, AA; Schalkwijk, CG; Schaper, N; Scheijen, J; Schram, MT; Sep, SJ; Smit, AJ; Stehouwer, CD; van der Kallen, CJ; van Eupen, MG; van Sloten, TT | 1 |
| Aberer, F; Brodmann, M; Dimsity, G; Hafner, F; Hödl, R; Hutz, B; Meinitzer, A; Riedl, R; Sourij, H; Stojakovic, T; Tripolt, NJ; Url, J | 1 |
| Du, MR; Jiang, JL; Ju, GX; Li, NS | 1 |
| Matsui, T; Nakamura, K; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Duran, C; Ipcioglu, OM; Ozcan, O; Unal, M; Yonem, A | 1 |
| Agarwal, SC; Böger, RH; Home, PD; Lüneburg, N; Schwedhelm, E; Sibal, L | 1 |
| Erdem, G; Tapan, S; Tasci, I | 1 |
| Anderssohn, M; Böger, RH; Lüneburg, N; Schwedhelm, E; Vasan, RS | 1 |
| Heidarianpour, A | 1 |
| Dalton, RN; Dunger, DB; Marcovecchio, ML; Turner, C; Widmer, B | 1 |
| Matsui, T; Yamagishi, S | 1 |
| Arend, A; Aunapuu, M; Avolio, AP; Butlin, M; Eha, J; Kals, J; Kampus, P; Põdramägi, T; Salum, E; Zilmer, M | 1 |
| Fayh, AP; Friedman, R; Krause, M; Moreira, JC; Reischak-Oliveira, A; Ribeiro, JL; Ribeiro, JP; Rodrigues-Krause, J | 1 |
| Eder, M; Meinitzer, A; Pieber, TR; Sourij, H; Tripolt, NJ; Wascher, TC | 1 |
| Ben Yahya, S; Bouzidi, H; Hammami, M; Kerkeni, M; Saïdi, A | 1 |
| Furfaro, AL; Monacelli, F; Odetti, P; Pronzato, MA; Puzzo, A; Sanguineti, R; Storace, D; Traverso, N | 1 |
| Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
| Böhm, F; Jung, C; Kövamees, O; Pernow, J; Rafnsson, A; Settergren, M; Shemyakin, A; Svenarud, P | 1 |
| Cheng, YS; Cong, XD; Dai, DZ; Dai, Y; Zhang, Y | 1 |
| Belcaro, G; Cesarone, MR; Ciammaichella, G; Dugall, M; Hosoi, M; Ippolito, E; Luzzi, R | 1 |
| Schwartz, L | 1 |
| Laakso, J; Laaksonen, R; Lehtimäki, T; Päivä, H; Pasternack, A; Rantalaiho, V; Ruokonen, I; Wirta, O | 1 |
| Adachi, T; Fukui, M; Hara, H; Hasegawa, G; Kimura, F; Kitagawa, Y; Nakamura, N; Nakano, K; Obayashi, H; Ohta, M; Park, H; Yoshikawa, T | 1 |
| Hovind, P; Parving, HH; Stehouwer, CD; Tarnow, L; Teerlink, T | 1 |
| Hirata, K; Kubo, K | 1 |
| Daimon, M; Hasegawa, R; Himi, T; Kawata, T; Komuro, I; Sekine, T; Teramoto, K; Toyoda, T; Uchida, D; Yamamoto, K; Yoshida, K | 1 |
| Goto, Y; Harano, Y; Kanda, M; Miyazaki, S; Nonogi, H; Suzuki, M; Yasuda, S | 1 |
| Etmüller, Y; Hofer, M; Kapiotis, S; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnabler, J; Shnawa, N; Wolzt, M | 1 |
| Ding, H; Triggle, CR | 1 |
| Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Bucciarelli, L; Ciabattoni, G; Clissa, C; Consoli, A; Davì, G; Devangelio, E; Ferroni, P; Formoso, G; Michetti, N; Santilli, F | 1 |
| Brownlee, M; Edelstein, D; Giardino, I; Hammes, HP; Matsumura, T; Pestell, R; Rabbani, N; Sarthy, VP; Suske, G; Taguchi, T; Thornalley, PJ; Yao, D | 1 |
| Kautzky-Willer, A; Langenberger, H; Mittermayer, F; Pacini, G; Pleiner, J; Schaller, G; Tura, A; Winzer, C; Wolzt, M | 1 |
| Jorsal, A; Lajer, M; Parving, HH; Rossing, P; Tarnow, L; Teerlink, T | 1 |
| Berchio, A; Bergamini, S; Brocato, L; Della Casa, L; Gigliardi, VR; Iannone, A; Manzato, E; Martina, V; Masha, A; Massarenti, P; Settanni, F | 1 |
| Bennetts, B; Craig, ME; Donaghue, KC; Duffin, AC; Gallego, PH; Hofer, S; Jenkins, AJ; Lam, A | 1 |
| Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG | 1 |
| Dai, FX; Diederich, A; Diederich, D; Skopec, J | 1 |
| Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
| Cooper, ME; Komers, R; Rumble, JR | 1 |
| Cameron, NE; Cotter, MA | 1 |
| Bailey, AJ; Oxlund, H; Rasmussen, LM; Sims, TJ | 1 |
| Adams, MB; Jordan, M; Pieper, GM; Roza, AM | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R | 1 |
| Clarkson, P; Deanfield, JE; Donald, AE; Mullen, MJ; Thorne, S | 1 |
| Donker, AJ; Schalkwijk, CG; Smulders, RA; Stehouwer, CD; TeKoppele, JM; van Hinsbergh, VW | 1 |
| Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
| Asahi, K; Horie, K; Inagi, R; Kurokawa, K; Miyata, T; Sakai, H; Uchida, K; Yamada, Y | 1 |
| Enderle, MD; Füllhase, J; Häring, HU; Karsch, KR; Koch, M; Kühn, R; Pfohl, M | 1 |
| Aubó, C; Marrugat, J; Masiá, R; Sala, J; Sentí, M; Tomás, M; Vila, J | 1 |
| Fedele, D; Lapolla, A; Traldi, P | 1 |
| Aricó, CN; Bernich, P; Brezzi, B; Lapolla, A; Lupo, A; Maiorca, P; Marcantoni, C; Maschio, G; Rugiu, C | 1 |
| Chang, K; Corbett, JA; Hasan, KS; Ido, Y; Lancaster, JR; McDaniel, ML; Sweetland, MA; Tilton, RG; Wang, JL; Williamson, JR | 1 |
| Fineberg, SE; McKusick, VA; Merimee, TJ; Siperstein, MD | 1 |
| Lohmann, D | 1 |
8 review(s) available for arginine and Diabetic Angiopathies
| Article | Year |
|---|---|
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Male; Risk Factors | 2019 |
Role of Asymmetrical Dimethylarginine in Diabetic Microvascular Complications.
Topics: Animals; Arginine; Biomarkers; Diabetes Mellitus; Diabetic Angiopathies; Enzyme Inhibitors; Humans; Nitric Oxide Synthase | 2016 |
Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
Topics: Amidohydrolases; Animals; Arginine; Diabetic Angiopathies; Humans; Nitric Oxide Synthase; Risk Factors | 2008 |
Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus.
Topics: Arginine; Diabetic Angiopathies; Endothelium, Vascular; Humans | 2010 |
Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?
Topics: Animals; Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Nitric Oxide; Nitric Oxide Synthase Type II | 2011 |
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.
Topics: Arginine; Biological Factors; Biomarkers; C-Reactive Protein; Cell Differentiation; Cell Proliferation; Cellular Senescence; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Humans; Hyperglycemia; Nitric Oxide; Oxidative Stress; Stem Cells; Vasodilation; Vasodilator Agents | 2005 |
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
The dialytic failure of the peritoneal membrane.
Topics: Aquaporin 1; Aquaporins; Arginine; Basement Membrane; Biological Transport; Blood Group Antigens; Body Water; Cross-Sectional Studies; Diabetic Angiopathies; Dialysis Solutions; Drug Packaging; Equipment Design; Female; Fibrosis; Glucose; Glycation End Products, Advanced; Glycosylation; Humans; Longitudinal Studies; Lysine; Male; Membrane Proteins; Molecular Weight; Osmotic Pressure; Oxidation-Reduction; Peritoneal Dialysis; Peritoneum; Peritonitis; Permeability; Sterilization; Time Factors; Treatment Failure | 2001 |
9 trial(s) available for arginine and Diabetic Angiopathies
| Article | Year |
|---|---|
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyruvaldehyde; Salicylates | 2014 |
Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease.
Topics: Aged; Aged, 80 and over; Arginine; Cell Adhesion Molecules; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Metformin; Middle Aged; Time Factors | 2015 |
Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
Topics: Acetylcholine; Aged; Arginase; Arginine; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; Nitroprusside; Ornithine; Peripheral Vascular Diseases; Severity of Illness Index; Vascular Resistance; Vasodilation; Vasodilator Agents | 2016 |
The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Austria; Biological Availability; Biomarkers; Brachial Artery; Clinical Protocols; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Humans; Linagliptin; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Effects of L-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes.
Topics: Adolescent; Adult; Arginine; Biomarkers; Blood Circulation; Brazil; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Exercise Test; Humans; Lower Extremity; Male; Motor Activity; Oxidative Stress; Regional Blood Flow; Risk Factors; Young Adult | 2013 |
Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.
Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors | 2012 |
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
Topics: Acetylcysteine; Administration, Oral; Aged; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Placebos; Systole | 2008 |
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Leg; Male; Middle Aged; Perindopril; Platelet Aggregation; Propanolamines; Reference Values; Regional Blood Flow; Rheology; Vascular Resistance | 1998 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
51 other study(ies) available for arginine and Diabetic Angiopathies
| Article | Year |
|---|---|
Lack of evidence of the correlation between plasma Asymmetrical Dimethylarginine correlation and IMT in type 2 diabetic patients with chronic vascular complication.
Topics: Adult; Aged; Arginine; Atherosclerosis; Carotid Artery, Internal; Carotid Intima-Media Thickness; Case-Control Studies; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Risk Factors; Ultrasonography, Doppler, Color | 2021 |
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Environment; Female; Genotype; Humans; Intermittent Claudication; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2014 |
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation | 2014 |
Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Breath Holding; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney; Male; Middle Aged; Outpatient Clinics, Hospital; Romania; Severity of Illness Index; Vasculitis, Central Nervous System | 2015 |
Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children.
Topics: Adolescent; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Male; Pediatric Obesity; Risk | 2015 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
ADMA: a specific biomarker for pathologic progress in diabetic microvascular complications?
Topics: Adult; Aged; Area Under Curve; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Logistic Models; Lysine; Male; Middle Aged; Odds Ratio; Prediabetic State; ROC Curve; Tandem Mass Spectrometry | 2016 |
Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
Topics: Adolescent; alpha-2-HS-Glycoprotein; Arginine; Biomarkers; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Cardiomyopathies; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Greece; Humans; Male; Osteoprotegerin; RANK Ligand; Reproducibility of Results | 2017 |
Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.
Topics: Aged; Arginase; Arginine; Biomarkers; Case-Control Studies; Citrulline; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Up-Regulation; Vasodilation | 2016 |
Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Middle Aged; Optical Imaging; Prospective Studies; Pulse Wave Analysis; Skin; Vascular Stiffness | 2016 |
Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy.
Topics: Aged; Albuminuria; Apelin; Arginine; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Fasting; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Oxidative Stress; Waist-Hip Ratio | 2009 |
A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
Topics: Adolescent; Adult; Albuminuria; Arginine; Biomarkers; Brachial Artery; Case-Control Studies; Cell Adhesion Molecules; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Male; Nitric Oxide Synthase Type III; Risk Factors; Ultrasonography; Vasodilation; Young Adult | 2009 |
The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus.
Topics: Apelin; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Endothelium, Vascular; Humans; Intercellular Signaling Peptides and Proteins; Life Style; Neovascularization, Pathologic | 2009 |
Does detraining restore influence of exercise training on microvascular responses in streptozotocin-induced diabetic rats?
Topics: Administration, Cutaneous; Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Inhibitors; Iontophoresis; Laser-Doppler Flowmetry; Male; Microcirculation; Microinjections; Microvessels; Nitric Oxide; Nitric Oxide Synthase; Physical Exertion; Rats; Rats, Wistar; Skin; Time Factors; Vasodilation; Vasodilator Agents | 2010 |
Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
Topics: Adolescent; Albuminuria; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Risk Factors | 2011 |
Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Arginine; Biomarkers; Blood Pressure; Cholecalciferol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dietary Supplements; Elastic Tissue; Elasticity; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Male; Pulsatile Flow; Radioimmunoassay; Rats; Rats, Wistar; Streptozocin; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Vitamin D | 2012 |
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Tunisia | 2012 |
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Diabetic Angiopathies; Extracellular Matrix; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-1alpha; Italy; Lysine; Matrix Metalloproteinase 2; Metalloproteases; Plaque, Atherosclerotic; Risk Factors; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-3 | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
Topics: Aged; Arginase; Arginine; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Forearm; Humans; Male; Middle Aged; Nitric Oxide; Vasodilation | 2012 |
Argirein alleviates corpus cavernosum dysfunction by suppressing pro-inflammatory factors p66Shc and ER stress chaperone Bip in diabetic rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Biomarkers; Diabetic Angiopathies; Dose-Response Relationship, Drug; Drug Combinations; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Erectile Dysfunction; Gene Expression Regulation; Guanidines; Heat-Shock Proteins; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Penis; Random Allocation; Rats; Rats, Sprague-Dawley; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Vasoconstriction; Vasodilation | 2013 |
Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy.
Topics: Administration, Cutaneous; Arginine; Carnosine; Dermatologic Agents; Diabetic Angiopathies; Diabetic Foot; Drug Combinations; Eczema; Female; Humans; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Middle Aged; Pilot Projects; Pressure; Product Surveillance, Postmarketing; Skin; Surveys and Questionnaires; Ultrasonography; Urea | 2012 |
Amelioration of microvascular angina with arginine supplementation.
Topics: Adult; Angina Pectoris; Arginine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Food, Fortified; Humans; Microcirculation | 2003 |
Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
Topics: Aged; Arginine; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Insulin; Linear Models; Male; Middle Aged; Risk Factors; Triglycerides | 2003 |
Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.
Topics: Amino Acid Substitution; Arginine; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glycated Hemoglobin; Glycine; Humans; Male; Microcirculation; Mutation, Missense; Phenotype; Predictive Value of Tests; Regression Analysis; Superoxide Dismutase | 2003 |
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Morbidity; Nitric Oxide Synthase | 2004 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve.
Topics: Aged; Arginine; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Microcirculation; Regression Analysis | 2005 |
Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synt
Topics: Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Nitric Oxide Synthase; Risk Factors; Tumor Necrosis Factor-alpha | 2006 |
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
Topics: Aged; Albuminuria; Arginine; Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2007 |
A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Topics: Arginine; Atherosclerosis; Cell Physiological Phenomena; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Glycation End Products, Advanced; Humans; Models, Biological; Nitric Oxide Synthase; Time Factors | 2007 |
Soluble RAGE in type 2 diabetes: association with oxidative stress.
Topics: Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2007 |
High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A.
Topics: Acetylglucosamine; Angiopoietin-2; Animals; Arginine; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Gene Expression Regulation; Glucose; Glycolysis; Intercellular Adhesion Molecule-1; Kidney; Mice; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Pyruvaldehyde; Repressor Proteins; Response Elements; Sin3 Histone Deacetylase and Corepressor Complex; Sp3 Transcription Factor; Sweetening Agents; Transcription, Genetic; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes.
Topics: Adult; Arginine; Body Mass Index; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Male; Nitric Oxide; Obesity; Pregnancy; Reference Values; Risk Factors; Sex Factors; Vasoconstriction; Vasodilation | 2007 |
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2008 |
Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes.
Topics: Adolescent; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Fasciitis, Plantar; Female; Glutamine; Humans; Leucine; Male; Methionine; New South Wales; Polymorphism, Single Nucleotide; White People | 2008 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea | 1993 |
Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals.
Topics: Animals; Arginine; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Fatty Acids, Unsaturated; Free Radical Scavengers; Free Radicals; Hydrazines; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandin Endoperoxides; Rats; Rats, Inbred WKY; Receptors, Thromboxane; Renal Artery; Superoxide Dismutase; Thiourea; Vasodilation | 1993 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Diabetic Angiopathies; Hypertrophy; Indoles; Kinins; Male; Mesenteric Arteries; Nitric Oxide; Nitroarginine; Perindopril; Rats; Rats, Wistar | 1996 |
Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
Topics: Animals; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
The role of glycation cross-links in diabetic vascular stiffening.
Topics: Adult; Aged; Aging; Amino Acids; Aorta, Thoracic; Arginine; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Elastin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Time Factors | 1996 |
Restoration of vascular endothelial function in diabetes.
Topics: Animals; Arginine; Blood Glucose; Diabetic Angiopathies; Endothelium, Vascular; Islets of Langerhans Transplantation; Male; Nitric Oxide; Rats; Rats, Inbred Lew; Vasodilation | 1996 |
Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine.
Topics: Adolescent; Adult; Aged; Arginine; Arteriosclerosis; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Male; Nitroglycerin; Risk Factors; Smoking; Vascular Resistance; Vasodilator Agents | 1998 |
Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; E-Selectin; Endothelium, Vascular; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Logistic Models; Lysine; Male; Middle Aged; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 1998 |
Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
Topics: Arachidonic Acid; Arginine; Arteriosclerosis; Ascorbic Acid; Diabetic Angiopathies; Glucose; Glycation End Products, Advanced; Glycosylation; Humans; Lipid Peroxidation; Lipoproteins; Lysine; Malondialdehyde; Oxidation-Reduction; Oxidative Stress | 1998 |
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Topics: Arginine; Aryldialkylphosphatase; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; DNA; Esterases; Female; Gene Frequency; Genotype; Glutamine; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic | 1999 |
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Topics: Aged; Arginine; Aryldialkylphosphatase; Case-Control Studies; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Esterases; Female; Genotype; Glutamine; Humans; Hyperlipidemias; Logistic Models; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic | 2000 |
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Blood Vessels; Cells, Cultured; Diabetic Angiopathies; Enzyme Activation; Glucose; Guanidines; Insulin; Interleukin-1; Islets of Langerhans; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Regional Blood Flow | 1992 |
The microangiopathic lesions of diabetes mellitus: an evaluation of possible causative factors.
Topics: Adult; Age Factors; Aged; Aneurysm; Arginine; Basement Membrane; Blood Glucose; Capillaries; Carbohydrate Metabolism; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Diagnosis, Differential; Dwarfism; Fundus Oculi; Glucose Tolerance Test; Growth Hormone; Humans; Hyperlipidemias; Insulin; Insulin Secretion; Metabolism, Inborn Errors; Microscopy, Electron; Middle Aged; Ophthalmoscopy; Time Factors; Triglycerides | 1970 |
[Studies of the free amino acids in blood serum in diabetics. (Total amino acids, arginine, proline and oxyproline)].
Topics: Adult; Age Factors; Amino Acids; Arginine; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Insulin; Male; Middle Aged; Proline | 1967 |